Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 5, 2006, Pages

  Chen, Xi Lin ^a   Dodd, Geraldine ^a   Thomas, Suzanne ^a   Zhang, Xiaolan ^b   Wasserman, Martin A ^a   Rovin, Brad H ^b   Kunsch, Charles ^a  

^a AtheroGenics Inc   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Antioxidant response element; Monocyte chemoattractant protein 1; Tumor necrosis factor ; Vascular cell adhesion molecule 1

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CELL ADHESION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MESANGIUM CELL; NATURAL KILLER CELL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIOXIDANTS; CELLS, CULTURED; CYTOKINES; CYTOPROTECTION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 33646418968     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00651.2005     Document Type: Article

References (46)

1. Ahmad M, Theofanidis P, and Medford RM. Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-α. J Biol Chem 273: 4616-4621, 1998.
2. Berk BC, Min W, Yan C, Surapisitchat J, Liu Y, and Hoefen R. Atheroprotective mechanisms activated by fluid shear stress in endothelial cells. Drug News Perspect 15: 133-139, 2002.
3. Braun S, Hanselmann C, Gassmann MG, auf dem Keller U, Born-Berclaz C, Chan K, Kan YW, and Werner S. Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol Cell Biol 22: 5492-5505, 2002.
4. Chan JY and Kwong M. Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein. Biochim Biophys Acta 1517: 19-26, 2000.
5. Chan K and Kan YW. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci USA 96: 12731-12736, 1999.
6. Chen XL and Kunsch C. Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases. Curr Pharm Des 10: 879-891, 2004.
7. Chen XL, Tummala PE, Olliff L, and Medford RM. E-selectin gene expression in vascular smooth muscle cells: evidence for a tissue-specific repressor protein. Circ Res 80: 305-311, 1997.
8. Chen XL, Varner SE, Rao AS, Grey JY, Thomas S, Cook CK, Wasserman MA, Medford RM, Jaiswal AK, and Kunsch C. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J Biol Chem 278: 703-711, 2003.
9. Cho HY, Jedlicka AE, Reddy SP, Kensler TW, Yamamoto M, Zhang LY, and Kleeberger SR. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 26: 175-182, 2002.
10. Cho HY, Reddy SP, Yamamoto M, and Kleeberger SR. The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J 18: 1258-1260, 2004.
11. Dhakshinamoorthy S and Jaiswal AK. Small Maf (MafG and MafK) proteins negatively regulate antioxidant response element-mediated expression and antioxidant induction of the NAD(P)H:Quinone oxidoreductase1 gene. J Biol Chem 275: 40134-40141, 2000.
12. Diamond JR and Karnovsky MJ. Focal and segmental glomerulosclerosis. Kidney Int 33: 917-924, 1988.
13. Hanazawa S, Takeshita A, Amano S, Semba T, Nirazuka T, Katoh H, and Kitano S. Tumor necrosis factor-α induces expression of monocyte chemoattractant JE via fos and jun genes in clonal osteoblastic MC3T3-E1 cells. J Biol Chem 268: 9526-9532, 1993.
14. Hirayama A, Yoh K, Nagase S, Ueda A, Itoh K, Morito N, Hirayama K, Takahashi S, Yamamoto M, and Koyama A. EPR imaging of reducing activity in Nrf2 transcriptional factor-deficient mice. Free Radic Biol Med 34: 1236-1242, 2003.
15. 2-terminal kinase activation via a glutathione reductase-mediated mechanism. Circ Res 91: 712-718, 2002.
16. Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, and Yamamoto M. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275: 16023-16029, 2000.
17. Ishikawa K and Maruyama Y. Heme oxygenase as an intrinsic defense system in vascular wall: implication against atherogenesis. J Atheroscler Thromb 8: 63-70, 2001.
18. Ishikawa K, Navab M, Leitinger N, Fogelman AM, and Lusis AJ. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 100: 1209-1216, 1997.
19. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, and Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236: 313-322, 1997.
20. Ju JW, Kim SJ, Jun CD, and Chun JS. p38 Kinase and c-Jun N-terminal kinase oppositely regulates tumor necrosis factor alpha-induced vascular cell adhesion molecule-1 expression and cell adhesion in chondrosarcoma cells. IUBMB Life 54: 293-299, 2002.
21. Katori M, Busuttil RW, and Kupiec-Weglinski JW. Heme oxygenase-1 system in organ transplantation. Transplantation 74: 905-912, 2002.
22. Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, Itabe H, Kodama T, and Maruyama Y. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 25: 155-160, 2005.
23. Keane WF, Kasiske BL, and O'Donnell MP. Lipids and progressive glomerulosclerosis: a model analogous to atherosclerosis. Am J Nephrol 8: 261-266, 1988.
24. Kunsch C, Luchoomun J, Chen XL, Dodd GL, Karu KS, Meng CQ, Marino EM, Olliff LK, Piper JD, Qiu FH, Sikorski JA, Somers PK, Suen KL, Thomas S, Whalen AM, Wasserman MA, and Sundell CL. AGIX-4207, a novel antioxidant and anti-inflammatory compound: cellular and biochemical characterization of antioxidant activity and inhibition of redox-sensitive inflammatory gene expression. J Pharmacol Exp Ther 313: 492-501, 2005.
25. Kunsch C, Luchoomun J, Grey JY, Olliff LK, Saint LB, Arrendale RF, Wasserman MA, Saxena U, and Medford RM. Selective inhibition of endothelial and monocyte redox-sensitive genes by AGI-1067: a novel antioxidant and anti-inflammatory agent. J Pharmacol Exp Ther 308: 820-829, 2004.
26. Lee JM, Calkins MJ, Chan K, Kan YW, and Johnson JA. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 278: 12029-12038, 2003.
27. Libby P. Inflammation in atherosclerosis. Nature 420: 868-874, 2002.
28. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, and Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92: 1866-1874, 1993.
29. Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, Perrella MA, Mitsialis SA, and Kourembanas S. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci USA 98: 8798-8803, 2001.
30. Pietersma A, Tilly BC, Gaestel M, de Jong N, Lee JC, Koster JF, and Sluiter W. p38 Mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem Biophys Res Commun 230: 44-48, 1997.
31. Poss KD and Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA 94: 10925-10930, 1997.
32. Prestera T and Talalay P. Electrophile and antioxidant regulation of enzymes that detoxify carcinogens. Proc Natl Acad Sci USA 92: 8965-8969, 1995.
33. Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, Kensler TW, Yamamoto M, Petrache I, Tuder RM, and Biswal S. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 114: 1248-1259, 2004.
34. Rovin BH, Dickerson JA, Tan LC, and Hebert CA. Activation of nuclear factor-κB correlates with MCP-1 expression by human mesangial cells. Kidney Int 48: 1263-1271, 1995.
35. Rovin BH, Wilmer WA, Danne M, Dickerson JA, Dixon CL, and Lu L. The mitogen-activated protein kinase p38 is necessary for interleukin 1β-induced monocyte chemoattractant protein 1 expression by human mesangial cells. Cytokine 11: 118-126, 1999.
36. Sasaki H, Sato H, Kuriyama-Matsumura K, Sato K, Maebara K, Wang H, Tamba M, Itoh K, Yamamoto M, and Bannai S. Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem 277: 44765-44771, 2002.
37. Soares MP, Seldon MP, Gregoire IP, Vassilevskaia T, Berberat PO, Yu J, Tsui TY, and Bach FH. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol 72: 3553-3563, 2004.
38. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, and Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 62: 5196-5203, 2002.
39. Tummala PE, Chen XL, and Medford RM. NF-κB independent suppression of endothelial vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 gene expression by inhibition of flavin binding proteins and superoxide production. J Mol Cell Cardiol 32: 1499-1508, 2000.
40. Wang X, McGowan CH, Zhao M, He L, Downey JS, Fearns C, Wang Y, Huang S, and Han J. Involvement of the MKK6-p38γ cascade in γ-radiation- induced cell cycle arrest. Mol Cell Biol 20: 4543- 4552, 2000.
41. Wild AC, Moinova HR, and Mulcahy RT. Regulation of γ- glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem 274: 33627-33636, 1999.
42. Xu W, Yan M, Lu L, Sun L, Theze J, Zheng Z, and Liu X. The p38 MAPK pathway is involved in the IL-2 induction of TNF-β gene via the EBS element. Biochem Biophys Res Commun 289: 979-986, 2001.
43. Yamawaki H, Haendeler J, and Berk BC. Thioredoxin: a key regulator of cardiovascular homeostasis. Circ Res 93: 1029-1033, 2003.
44. Yamawaki H, Lehoux S, and Berk BC. Chronic physiological shear stress inhibits tumor necrosis factor-induced proinflammatory responses in rabbit aorta perfused ex vivo. Circulation 108: 1619-1625, 2003.
45. Yoh K, Itoh K, Enomoto A, Hirayama A, Yamaguchi N, Kobayashi M, Morito N, Koyama A, Yamamoto M, and Takahashi S. Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int 60: 1343-1353, 2001.
46. Zhang X, Lu L, Dixon C, Wilmer W, Song H, Chen X, and Rovin BH. Stress protein activation by the cyclopentenone prostaglandin 15-deoxydelta12,14- prostaglandin J2 in human mesangial cells. Kidney Int 65: 798-810, 2004.